131 related articles for article (PubMed ID: 38198126)
1. When treatment takes a turn: tocilizumab-induced bowel perforation in a patient with COVID-19-afflicted rheumatoid arthritis.
Yoo WH; Ha GW; Kim KM; Choi Y
Scand J Rheumatol; 2024 Mar; 53(2):155-157. PubMed ID: 38198126
[No Abstract] [Full Text] [Related]
2. Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review.
Gout T; Ostör AJ; Nisar MK
Clin Rheumatol; 2011 Nov; 30(11):1471-4. PubMed ID: 21833686
[TBL] [Abstract][Full Text] [Related]
3. Multiple upper gastrointestinal perforations in a 15-year-old patient treated with tocilizumab.
Pfeil J; Grulich-Henn J; Wenning D; Breil T; Günther P; Lutz T
Rheumatology (Oxford); 2014 Sep; 53(9):1713-4. PubMed ID: 24625503
[No Abstract] [Full Text] [Related]
4. Toxidermia under treatment with tocilizumab for rheumatoid arthritis.
Fechtenbaum M; Banse C; Boyard-Lasselin P; Goëb V
Joint Bone Spine; 2015 Jan; 82(1):69-70. PubMed ID: 25048098
[No Abstract] [Full Text] [Related]
5. Tocilizumab-induced leucocytoclastic vasculitis in a patient with rheumatoid arthritis.
Sakaue S; Sumitomo S; Kubo K; Fujio K; Yamamoto K
Rheumatology (Oxford); 2014 Aug; 53(8):1529-30. PubMed ID: 24609062
[No Abstract] [Full Text] [Related]
6. Rheumatoid neutrophilic dermatitis in a patient taking tocilizumab for treatment of rheumatoid arthritis.
Kubota N; Ito M; Sakauchi M; Kobayashi K
J Dermatol; 2017 Jul; 44(7):e180-e181. PubMed ID: 28342172
[No Abstract] [Full Text] [Related]
7. Psoriasis onset with tocilizumab.
Grasland A; Mahé E; Raynaud E; Mahé I
Joint Bone Spine; 2013 Oct; 80(5):541-2. PubMed ID: 23731639
[No Abstract] [Full Text] [Related]
8. Exacerbation of combined pulmonary fibrosis and emphysema syndrome during tocilizumab therapy for rheumatoid arthritis.
Wendling D; Vidon C; Godfrin-Valnet M; Rival G; Guillot X; Prati C
Joint Bone Spine; 2013 Dec; 80(6):670-1. PubMed ID: 23618802
[No Abstract] [Full Text] [Related]
9. Social media for arthritis-related comparative effectiveness and safety research and the impact of direct-to-consumer advertising.
Curtis JR; Chen L; Higginbotham P; Nowell WB; Gal-Levy R; Willig J; Safford M; Coe J; O'Hara K; Sa'adon R
Arthritis Res Ther; 2017 Mar; 19(1):48. PubMed ID: 28270190
[TBL] [Abstract][Full Text] [Related]
10. Tocilizumab-induced pulmonary fibrosis in a patient with rheumatoid arthritis.
Silva S; Amarasena R; Moorcroft J; Rajakulenthiran T; Singh R
Clin Med (Lond); 2020 Mar; 20(Suppl 2):s57. PubMed ID: 32409376
[No Abstract] [Full Text] [Related]
11. Ramsay Hunt syndrome associated with tocilizumab therapy in rheumatoid arthritis: a case report.
Mimata Y; Akasaka T; Nakano R; Murata T; Kawashima M; Shimamura T
Int J Rheum Dis; 2013 Jun; 16(3):367-8. PubMed ID: 23981764
[No Abstract] [Full Text] [Related]
12. [Intestinal perforation in patient with COVID-19 infection treated with tocilizumab and corticosteroids. Report of a clinical case].
Gonzálvez Guardiola P; Díez Ares JÁ; Peris Tomás N; Sebastián Tomás JC; Navarro Martínez S
Cir Esp (Engl Ed); 2021 Feb; 99(2):156-157. PubMed ID: 32402416
[No Abstract] [Full Text] [Related]
13. FDA approves tocilizumab to treat rheumatoid arthritis.
Thompson CA
Am J Health Syst Pharm; 2010 Feb; 67(4):254. PubMed ID: 20133526
[No Abstract] [Full Text] [Related]
14. Tocilizumab (Actemra) for rheumatoid arthritis.
Med Lett Drugs Ther; 2010 Jun; 52(1340):47-8. PubMed ID: 20539266
[No Abstract] [Full Text] [Related]
15. Sarcoidosis induced by tocilizumab: a paradoxical event?
Nutz A; Pernet C; Combe B; Cohen JD
J Rheumatol; 2013 Oct; 40(10):1773-4. PubMed ID: 24085760
[No Abstract] [Full Text] [Related]
16. Retention rates of infliximab and tocilizumab during a 3-year period in a Brazilian hospital.
Golmia RP; Scheinberg MA
Einstein (Sao Paulo); 2013 Dec; 11(4):492-4. PubMed ID: 24488390
[TBL] [Abstract][Full Text] [Related]
17. Tocilizumab: new drug. Rheumatoid arthritis: another 'mab', no therapeutic advantage.
Prescrire Int; 2009 Oct; 18(103):198-201. PubMed ID: 19882783
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid factor appearance after tocilizumab treatment seems to predict bad therapeutical response in rheumatoid arthritis.
Faillace C; de Carvalho JF
Rheumatol Int; 2013 Jul; 33(7):1909-10. PubMed ID: 22441966
[No Abstract] [Full Text] [Related]
19. Tocilizumab-induced psoriasiform rash in rheumatoid arthritis.
Palmou-Fontana N; Sánchez Gaviño JA; McGonagle D; García-Martinez E; Iñiguez de Onzoño Martín L
Dermatology; 2014; 228(4):311-3. PubMed ID: 24942661
[TBL] [Abstract][Full Text] [Related]
20. [Clinical effect of tocilizumab on patients with severe active rheumatoid arthritis].
Xu S; Xie X; Tang M; Chen J; Tian J; Du J; Mao N; Liu Y; Li S; Song M; Gao J; Ling G; Li F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 42(10):1174-1177. PubMed ID: 29093249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
